| Thrombopoietin and mean platelet volume in coronary artery disease H Şenaran, M Ileri, A AltinbaŞ, A KoŞar, E Yetkin, M ÖZTÜRK, ... Clinical cardiology 24 (5), 405-408, 2001 | 288 | 2001 |
| Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity S Haliloglu, A Carlioglu, D Akdeniz, Y Karaaslan, A Kosar Rheumatology international 34, 1275-1280, 2014 | 209 | 2014 |
| A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis Ankara Rheumatology Study Group, S Pay, N Türkçapar, M Kalyoncu, ... Clinical rheumatology 25, 639-644, 2006 | 153 | 2006 |
| Superoxide dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: effects of different treatment modalities M Isler, N Delibas, M Guclu, F Gultekin, R Sutcu, M Bahceci, A Kosar Croatian medical journal 43 (1), 16-19, 2002 | 149 | 2002 |
| In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin HS Cipil, A Kosar, A Kaya, B Uz, IC Haznedaroglu, H Goker, O Ozdemir, ... Clinical and Applied Thrombosis/Hemostasis 15 (3), 270-276, 2009 | 148 | 2009 |
| Hemostatic efficacy of Ankaferd Blood Stopper® in a swine bleeding model H Bilgili, A Kosar, M Kurt, IK Onal, H Goker, O Captug, A Shorbagi, ... Medical Principles and Practice 18 (3), 165-169, 2009 | 127 | 2009 |
| Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper BZ Haznedaroglu, IC Haznedaroglu, SL Walker, H Bilgili, H Goker, ... Clinical and Applied Thrombosis/Hemostasis 16 (4), 446-453, 2010 | 104 | 2010 |
| The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model A Kosar, HS Cipil, A Kaya, B Uz, IC Haznedaroglu, H Goker, O Ozdemir, ... Blood coagulation & fibrinolysis 20 (3), 185-190, 2009 | 99 | 2009 |
| The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model A Kosar, HS Cipil, A Kaya, B Uz, IC Haznedaroglu, H Goker, O Ozdemir, ... Blood coagulation & fibrinolysis 20 (3), 185-190, 2009 | 99 | 2009 |
| Treating erectile dysfunction with a vacuum tumescence device: a retrospective analysis of acceptance and satisfaction S Baltaci, K AYDOS, A Kosar, K Anafarta British journal of urology 76 (6), 757-760, 1995 | 93 | 1995 |
| Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy? N Bavbek, A Kargili, O Kaftan, F Karakurt, A Kosar, A Akcay Clinical and Applied Thrombosis/Hemostasis 13 (4), 391-397, 2007 | 81 | 2007 |
| Oral systemic administration of Ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model H Bilgili, O Captug, A Kosar, M Kurt, M Kekilli, A Shorbagi, OK Kurt, ... Clinical and Applied Thrombosis/Hemostasis 16 (5), 533-536, 2010 | 80 | 2010 |
| Neutrophil-lymphocyte ratio (NLR) could be better predictor than C-reactive protein (CRP) for liver fibrosis in non-alcoholic steatohepatitis (NASH) H Yilmaz, KS Yalcin, M Namuslu, HT Celik, M Sozen, O Inan, I Nadir, ... Annals of Clinical & Laboratory Science 45 (3), 278-286, 2015 | 69 | 2015 |
| Selectin adhesion molecules in Behcet's disease Ş Haznedaroǧlu, Y Karaaslan, Y Büyükaşık, A Koşar, Ş Kirazlı, ... Annals of the rheumatic diseases 59 (1), 61-63, 2000 | 69 | 2000 |
| Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases A Kargılı, N Bavbek, A Kaya, A Koşar, Y Karaaslan Rheumatology international 24, 321-324, 2004 | 55 | 2004 |
| Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study A Kosar, B Kasapoglu, S Kalyoncu, H Turan, OS Balcik, EI Gümüs Blood Coagulation & Fibrinolysis 22 (1), 14-18, 2011 | 52 | 2011 |
| Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in … A Kosar, S Haznedaroglu, Y Karaaslan, Y Büyükasik, IC Haznedaroglu, ... Rheumatology international 19, 11-14, 1999 | 51 | 1999 |
| Incidence and etiology of thrombocytosis in an adult Turkish population Tİİ Aydogan, M Kanbay, O Alİcİ, Aİ Kosar Platelets 17 (5), 328-331, 2006 | 45 | 2006 |
| Serum beta 2-microglobulin reflects disease activity in Behçet's disease M Aygündüz, N Bavbek, M Öztürk, O Kaftan, A Koşar, Ş Kirazli Rheumatology international 22, 5-8, 2002 | 45 | 2002 |
| Long-term pulmonary complications of chemical warfare agent exposure in Iraqi Kurdish civilians M Ghanei, M Naderi, AM Kosar, AA Harandi, NS Hopkinson, Z Poursaleh Inhalation toxicology 22 (9), 719-724, 2010 | 44 | 2010 |
